BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28646023)

  • 21. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
    Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
    Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and developmental expression of the murine homolog of the acute leukemia proto-oncogene AF4.
    Baskaran K; Erfurth F; Taborn G; Copeland NG; Gilbert DJ; Jenkins NA; Iannaccone PM; Domer PH
    Oncogene; 1997 Oct; 15(16):1967-78. PubMed ID: 9365243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling.
    Lerchenmüller C; Heißenberg J; Damilano F; Bezzeridis VJ; Krämer I; Bochaton-Piallat ML; Hirschberg K; Busch M; Katus HA; Peppel K; Rosenzweig A; Busch H; Boerries M; Most P
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1854-67. PubMed ID: 27386938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A6 protein: functional roles.
    Donato R; Sorci G; Giambanco I
    Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioimaging analysis of nuclear factor-κB activity in Philadelphia chromosome-positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor-α-stimulated changes to the microenvironment.
    Tsai HJ; Kobayashi S; Izawa K; Ishida T; Watanabe T; Umezawa K; Lin SF; Tojo A
    Cancer Sci; 2011 Nov; 102(11):2014-21. PubMed ID: 21777350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy- (Blinatumomab-) Related Lineage Switch of
    He RR; Nayer Z; Hogan M; Cuevo RS; Woodward K; Heyer D; Curtis CA; Peterson JF
    Case Rep Hematol; 2019; 2019():7394619. PubMed ID: 31885955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
    Einsiedel HG; Kawan L; Eckert C; Witt O; Fichtner I; Henze G; Seeger K
    Leukemia; 2006 Aug; 20(8):1435-6. PubMed ID: 16810202
    [No Abstract]   [Full Text] [Related]  

  • 29. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.
    Shi PJ; Xu LH; Lin KY; Weng WJ; Fang JP
    J Hematol Oncol; 2016 Feb; 9():12. PubMed ID: 26892465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous TNFalpha mediates cell survival and chemotherapy resistance by activating the PI3K/Akt pathway in acute lymphoblastic leukemia cells.
    Gu L; Findley HW; Zhu N; Zhou M
    Leukemia; 2006 May; 20(5):900-4. PubMed ID: 16511511
    [No Abstract]   [Full Text] [Related]  

  • 32. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
    Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein.
    Okada M; Tokumitsu H; Kubota Y; Kobayashi R
    Biochem Biophys Res Commun; 2002 Apr; 292(4):1023-30. PubMed ID: 11944917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.
    Sobiak J; Kazimierczak U; Kowalczyk DW; Chrzanowska M; Styczyński J; Wysocki M; Szpecht D; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):385-95. PubMed ID: 26040247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL.
    Guo Y; Li Y; Xiang B; Huang XO; Ma HB; Wang FF; Gong YP
    Biochem J; 2017 Dec; 474(24):4153-4170. PubMed ID: 29046392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated S100A6 (Calcyclin) enhances tumorigenesis and suppresses CXCL14-induced apoptosis in clear cell renal cell carcinoma.
    Lyu XJ; Li HZ; Ma X; Li XT; Gao Y; Ni D; Shen DL; Gu LY; Wang BJ; Zhang Y; Zhang X
    Oncotarget; 2015 Mar; 6(9):6656-69. PubMed ID: 25760073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A6 mediates nuclear translocation of Sgt1: a heat shock-regulated protein.
    Prus W; Filipek A
    Amino Acids; 2011 Oct; 41(4):781-7. PubMed ID: 20213445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of MLL-1/AF4 recombination in infant acute lymphoblastic leukemia.
    Borkhardt A; Repp R; Haupt E; Brettreich S; Buchen U; Gossen R; Lampert F
    Leukemia; 1994 Apr; 8(4):549-53. PubMed ID: 8152249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription.
    Lu H; Li Z; Zhang W; Schulze-Gahmen U; Xue Y; Zhou Q
    Nucleic Acids Res; 2015 Jul; 43(12):5868-79. PubMed ID: 26007649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.